Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!

Product Image
Product Description

Designed specifically for the SpectraMax® i3 Multi-Mode Detection Platform, the field-upgradeable SpectraMax MiniMax™ 300 Imaging Cytometer option enables quick inspection of cells and provides insight into phenotypic changes that are important for understanding cytotoxicity, cell proliferation, and protein expression.

The SpectraMax® MiniMax™ 300 Imaging Cytometer option offers cellular imaging capability, and much more:

  • Simplified workflow: Cell and whole-well assays in a small footprint
  • No Stain Analysis: Eliminate cell staining for cell counting and confluency measurements using StainFree™ Technology
  • More data: Multi-parametric cell-based assays with brightfield and green and red fluorescent imaging
  • Familiar software: Set up, image and analyze cells in a snap using SoftMax® Pro Microplate Data Acquisition & Analysis Software
  • Higher sensitivity: Easily measure low cell concentration samples
  • Lower variance: Normalize your plate data to the number of cells in each well

The SpectraMax MiniMax™ 300 enables the following applications:

  • Cell Count/Viability
  • Cell Proliferation/Cytotoxicity
  • Marker Expression

Imaging cell-based assays typically requires the use of fluorescent probes that can be toxic to living cells or may require fixation. A label-free method for analyzing cell counts and cell confluence enables researchers to quantitatively monitor cell proliferation and health without time-consuming workflows that may disrupt cell viability.

The SpectraMax® i3 Multi-Mode Microplate Platform with MiniMax™ 300 Imaging Cytometer uses StainFree™ Cell Detection Technology so that you can perform cell proliferation, cytotoxicity, and other assays without fluorescent labels. For assays requiring multi-color detection and analysis, the SpectraMax MiniMax Imaging Cytometer now offers two channels of fluorescence, along with new cell analysis and classification methods.

This versatility is powered by SoftMax® Pro software with novel algorithms for object recognition providing multi-parametric outputs for a wide range of cell-based assays. An intuitive user interface lets even non-imaging specialists to get up and running quickly.

In our poster we demonstrate how this platform can be used to obtain more biologically relevant data. StainFree Technology enables cell counting comparable to fluorescent nuclear counts. IC50 curves for compound-treated cells obtained through StainFree analysis are presented. Cell viability assessment using the EarlyTox™ Cell Integrity assay plus
classification feature in SoftMax Pro software provide detailed information on compound
effects. Plate reader assays using luminescence or other detection modes of the
SpectraMax i3 platform can easily be combined with imaging cytometry to obtain more
information on the mechanisms of cell toxicity.

Click the more information link to register to download our poster and data sheet and imagine the possibilities.

SpectraMax-MiniMax-Datasheet-rev-C-(MiniMax-300)-1-Image-300w-web.jpg

Product SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!
Company Molecular Devices
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices
660 - 665 Eskdale Road Winnersh Triangle Wokingham Berkshire RG41 5TS

Tel: +44-118-944-8000
Fax: +44-118-944-8001
Email: infoboxeu@moldev.com



Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!